Search for: "Geneva Pharmaceuticals"
Results 101 - 120
of 167
Sort by Relevance
|
Sort by Date
27 Sep 2010, 1:14 pm
" Author Robert Elliott, executive vice president, Amaxx Risks Solutions, Inc. has worked successfully for 20 years with many industries to reduce Workers Compensation costs, including airlines, healthcare, printing/publishing, pharmaceuticals, retail, hospitality and manufacturing. [read post]
15 Sep 2010, 7:01 am
Several of these companies reported substantial growth in R&D expenditure including a number of pharmaceutical firms. [read post]
4 Sep 2010, 8:29 pm
" Geneva Pharm., Inc. v. [read post]
5 Aug 2010, 2:03 pm
See, Sun Pharmaceutical Industries v. [read post]
2 Aug 2010, 5:00 am
Sun Pharmaceutical Industries, Ltd. v. [read post]
28 Jul 2010, 5:04 pm
Sun Pharmaceutical v. [read post]
15 Jul 2010, 3:50 am
The Rice Products from the United States of America (Restriction on First Placing on the Market) (Wales) (Revocation) Regulations 2010 The National Health Service (Miscellaneous Amendments Relating to Independent Prescribing) (Wales) Regulations 2010 The National Health Service (Pharmaceutical Services) (Amendment) (Wales) (No. 2) Regulations 2010 The Geneva Conventions and United Nations Personnel (Protocols) Act 2009 (Commencement No.2) Order 2010 The Conduct of Employment… [read post]
14 Jun 2010, 6:30 pm
Geneva Pharmaceuticals, Inc., 344 F.3d 1294 (11th Cir. 2003). [read post]
1 Jun 2010, 12:50 am
Reports indicate that a major concern involves the possible seizure of goods in transit, which raises access to medicines fears with the potential detention of generic pharmaceuticals. [read post]
27 May 2010, 3:20 am
Anchen Pharmaceuticals Inc et al. [read post]
27 Apr 2010, 10:58 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: Kenya High Court suspends Anti-Counterfeiting Act ‘in as far as it applies to generic medicines’ (Afro-IP) (Michael Geist) India: Roche and Tarceva in Delhi HC again, this time vs Natco (Spicy IP) (Generic Pharmaceuticals and IP) Ecuador: Compulsory license granted to Cipla for Lopinavir + Ritonavir (Generic… [read post]
12 Apr 2010, 3:06 am
and Maria Gagliardi Italian report on Insurance law between business law and consumer law News/Annonces /NoticiasComparative Health Care Liability and Regulation:A Technology-Based Approach – International Summer School Pisa, Italy 24th – 4th June 2010New Frontiers of Pharmaceutical Law - Young Researchers WorkshopLecce, Italy, 6th and 7th of May 2010 "What Price for the Community Enforcement of WTO Dispute Settlement Body’s Rulings? [read post]
26 Feb 2010, 4:17 pm
Novartis Pharmaceuticals Corp.; Simonian v. [read post]
26 Nov 2009, 9:36 pm
If it was a pharmaceutical company, the suit would be brought as a products liability case. [read post]
26 Nov 2009, 9:36 pm
If it was a pharmaceutical company, the suit would be brought as a products liability case. [read post]
13 Nov 2009, 1:31 pm
” (More here) Large Hadron Particle Collider Punk’d By Time Traveling Bird The Large Hadron Collider (LHC), outside Geneva, was shut down by a “bit of baguette” after a passing bird may have dropped the chunk of bread on an electrical substation above the accelerator, causing a power cut. [read post]
26 Jun 2009, 9:17 am
Innovation functions as a public private partnership; according to current research by Ashley Stevens at Boston University the vast majority of FDA (Food and Drug Administration) approved pharmaceuticals were developed with public sector support. [read post]
17 Jun 2009, 9:49 pm
This piece has been specially crafted for the blog by Itaru Nitta, Green Intellectual Property Project, Geneva, Switzerland. [read post]
12 Jun 2009, 12:10 pm
Geneva Pharmaceuticals, Inc., 344 F.3d 1294 (11th Cir. 2003). [read post]
12 Mar 2009, 9:59 pm
See AP's "Roche to take over Genentech": GENEVA (March 12)--Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn't already own, ending a long corporate struggle with its U.S. [read post]
